Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis
Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska
Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska
View: Text | PDF
Research Article Immunology Infectious disease

Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis

  • Text
  • PDF
Abstract

Sepsis survivors suffer from increased vulnerability to infections, and lymphopenia presumably contributes to this problem. The mechanisms of the recovery of memory CD4+ T cells after sepsis remain elusive. We used the cecal ligation and puncture mouse model of sepsis to study the restoration of the memory CD4+ T cells during recovery from sepsis. Then, adoptive transfer of antigen-specific naive CD4+ T cells followed by immunization and BrdU labeling were performed to trace the proliferation and migration of memory CD4+ T cells. We revealed that the bone marrow (BM) is the primary site of CD4+ memory T cell homing and proliferation after sepsis-induced lymphopenia. Of interest, BM CD4+ T cells had a higher basal proliferation rate in comparison with splenic T cells. These cells also show features of resident memory T cells yet have the capacity to migrate outside the BM niche and engraft secondary lymphoid organs. The BM niche also sustains viability and functionality of CD4+ T cells. We also identified IL-7 as the major inducer of proliferation of the BM memory CD4+ T cells and showed that recombinant IL-7 improves the recovery of these cells. Taken together, we provide data on the mechanism and location of memory CD4+ T cell proliferation during recovery from septic lymphopenia, which are of relevance in studying immunostimulatory therapies in sepsis.

Authors

Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska

×

Figure 5

The capacity of T cell homing toward the BM niche is decreased in sepsis.

Options: View larger image (or click on image) Download as PowerPoint
The capacity of T cell homing toward the BM niche is decreased in sepsis...
(A) Experimental design. CD3+ T cells were purified from healthy or post-CLP mice on day 6. Then cells were labeled with CTV and transplanted into healthy or post-CLP mice (on day 6). Twenty-four hours later fluorescently labeled cells were analyzed by flow cytometry. (B) Normalized ratio of the number of donor-origin splenic T cells in the lymph nodes or BM of recipient mice versus the number of donor-origin cells in the spleen (n = 5–8 in each group). (C) Normalized ratio of the number of donor-origin BM T cells in the lymph nodes or BM of recipient mice versus the number of donor-origin cells in the spleen. Box-and-whiskers plot presents p25-p75 (box), mean, and p10-p90 (whiskers). Data from 2 independent experiments (n = 5–8 in each group). *P < 0.05, ****P < 0.0001, §§§P < 0.001, and §§§§P < 0.0001 for differences between CD3 ratio in the lymph nodes of healthy-healthy and other combinations using ANOVA with Tukey’s post hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts